The Biden administration is expected to release the next batch of drugs that will be subject to Medicare price negotiations — ...

The government-funded insurance plan will now pay for the drug for patients with obstructive sleep apnea, a condition that ...

British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?